Erratum: Advances in pharmacogenomics and individualized drug therapy: Exciting challenges that lie ahead (European Journal of Pharmacology (2004) 500 (267-280) DOI: 10.1016/j.ejphar.2004.07.031);Advances in pharmacogenomics and individualized drug therapy: Exciting challenges that lie ahead

European Journal of Pharmacology

Volumn 500, Issue 1-3 SPEC. ISS., 2004, Pages 267-280

  Nebert, Daniel W ^a   Vesell, Elliot S ^b  

^a Dept Environ Hlth Ctr E ^*  (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Drug therapy; Gene; Pharmacogenomics

Indexed keywords

GEFITINIB;

ACCURACY; GENETIC TRANSCRIPTION; GENOTYPE; INDIVIDUALITY; NUCLEOTIDE SEQUENCE; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 4644359361     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.11.010     Document Type: Erratum

References (152)

1. Anderson, W., Nov. 2003. Presentation at International Symposium on Pharmacogenomics: Impact on Clinical Trials, sponsored by the National institute of Toxicological Research, Seoul, Korea. http://www.kfda.go.kr/
2. E.C. Anderson, and M. Slatkin Population-genetic basis of haplotype blocks in the 5q31 region Am. J. Hum. Genet. 74 2004 40 49
3. O.A. Andreassen, B.G. Jenkins, A. Dedeoglu, K.L. Ferrante, M.B. Bogdanov, R. Kaddurah-Daouk, and M.F. Beal Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation J. Neurochem. 77 2001 383 390
4. M. Arranz, D. Collier, M. Sodhi, D. Ball, G. Roberts, J. Price, P. Sham, and R. Kerwin Association between clozapine response and allelic variation in 5-HT2A receptor gene Lancet 346 1995 281 282
5. M.J. Bamshad, S. Wooding, W.S. Watkins, C.T. Ostler, M.A. Batzer, and L.B. Jorde Human population genetic structure and inference of group membership Am. J. Hum. Genet. 72 2003 578 589
6. 2-Macroglobulin is genetically associated with Alzheimer disease Nat. Genet. 19 1998 357 360
7. W.J. Blake, M. Kaern, C.R. Cantor, and J.J. Collins Noise in eukaryotic gene expression Nature 422 2003 633 637
8. M. Blum, D.M. Grant, W. McBride, M. Heim, and U.A. Meyer Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression DNA Cell Biol. 9 1990 193 203
9. 1H-NMR-based metabonomics Nat. Med. 8 2002 1439 1444
10. J.R. Burke, M.S. Wingfield, K.E. Lewis, A.D. Roses, J.E. Lee, C. Hulette, M.A. Pericak-Vance, and J.M. Vance The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family Nat. Genet. 7 1994 521 524
11. P.W. Burnet, and P.J. Harrison Genetic variation of the 5-HT2A receptor and response to clozapine Lancet 346 1995 909
12. C.J. Campbell, and P. Ghazal Molecular signatures for diagnosis of infection: application of microarray technology J. Appl. Microbiol. 96 2004 18 23
13. C.S. Carlson, M.A. Eberle, M.J. Rieder, J.D. Smith, L. Kruglyak, and D.A. Nickerson Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans Nat. Genet. 33 2003 518 521
14. C.S. Carlson, M.A. Eberle, M.J. Rieder, Q. Yi, L. Kruglyak, and D.A. Nickerson Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium Am. J. Hum. Genet. 74 2004 106 120
15. S.B. Carroll Genetics and the making of Homo sapiens Nature 422 2003 849 857
16. M.H. Cheok, W. Yang, C.H. Pui, J.R. Downing, C. Cheng, C.W. Naeve, M.V. Relling, and W.E. Evans Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells Nat. Genet. 34 2003 85 90
17. M. Cherkaoui-Malki, K. Meyer, W.Q. Cao, N. Latruffe, A.V. Yeldandi, M.S. Rao, C.A. Bradfield, and J.K. Reddy Identification of novel peroxisome proliferator-activated receptor-α (PPARα) target genes in mouse liver using cDNA microarray analysis Gene Expr. 9 2001 291 304
18. A.G. Clark, R. Nielsen, J. Signorovitch, T.C. Matise, S. Glanowski, J. Heil, E.S. Winn-Deen, A.L. Holden, and E. Lai Linkage disequilibrium and inference of ancestral recombination in 538 single-nucleotide polymorphism clusters across the human genome Am. J. Hum. Genet. 73 2003 285 300
19. D.C. Crawford, C.S. Carlson, M.J. Rieder, D.P. Carrington, Q. Yi, J.D. Smith, M.A. Eberle, L. Kruglyak, and D.A. Nickerson Haplotype diversity across 100 candidate genes for inflammation, lipid metabolism, and blood pressure regulation in two populations Am. J. Hum. Genet. 74 2004 610 622
20. M.E. Curran, I. Splawski, K.W. Timothy, G.M. Vincent, E.D. Green, and M.T. Keating A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome Cell 80 1995 795 803
21. D. Dai, J. Tang, R. Rose, E. Hodgson, R.J. Bienstock, H.W. Mohrenweiser, and J.A. Goldstein Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos J. Pharmacol. Exp. Ther. 299 2001 825 831
22. D. Dai, D.C. Zeldin, J.A. Blaisdell, B. Chanas, S.J. Coulter, B.I. Ghanayem, and J.A. Goldstein Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid Pharmacogenetics 11 2001 597 607
23. M. Dean Approaches to identify genes for complex human diseases: lessons from Mendelian disorders Human Mutat. 22 2003 261 274
24. S.M. de Morais, H. Schweikl, J. Blaisdell, and J.A. Goldstein Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18 Biochem. Biophys. Res. Commun. 194 1993 194 201
25. S.M. de Morais, G.R. Wilkinson, J. Blaisdell, K. Nakamura, U.A. Meyer, and J.A. Goldstein The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans J. Biol. Chem. 269 1994 15419 15422
26. E.T. Dermitzakis, A. Reymond, N. Scamuffa, C. Ucla, E. Kirkness, C. Rossier, and S.E. Antonarakis Evolutionary discrimination of mammalian conserved non-genic sequences (CNGs) Science 302 2003 1033 1055
27. P.W. Doetsch Translesion synthesis by RNA polymerases: occurrence and biological implications for transcriptional mutagenesis Mutat. Res. 510 2002 131 140
28. S.M. Domchek, and B.L. Weber Recent advances in breast cancer biology Curr. Opin. Oncol. 14 2002 589 593
29. G. Dover Molecular drive Trends Genet. 18 2002 587 589
30. 2-Macroglobulin polymorphism and Alzheimer disease risk in the UK Nat. Genet. 22 1999 16 17
31. Eichelbaum, M., 1975. Ein neuendeckte defect im ArzneiMittelstoffwechsel des Menschen: die fahlende N-Oxydation des Spartein [thesis]. University of Bonn.
32. R. Etzioni, N. Urban, S. Ramsey, M. McIntosh, S. Schwartz, B. Reid, J. Radich, G. Anderson, and L. Hartwell The case for early detection Nat. Rev., Cancer 3 2003 243 252
33. W.E. Evans, and H.L. McLeod Pharmacogenomics-drug disposition, drug targets, and side effects N. Engl. J. Med. 348 2003 538 549
34. D.A. Evans, K.A. Manley, and V.A. McKusick Genetic control of isoniazid metabolism in man Br. Med. J. 13 1960 485 491
35. B. Funalot, O. Varenne, and J.L. Mas A call for accurate phenotype definition in the study of complex disorders Nat. Genet. 36 2004 3
36. N. Galtier Gene conversion drives GC content evolution in mammalian histones Trends Genet. 19 2003 65 68
37. M. Geldmacher-von Mallinckrodt, G. Hommel, and J. Dumbach On the genetics of the human serum paraoxonase (EC 3.1.1.2) Hum. Genet. 50 1979 313 326
38. J.B. German, M.A. Roberts, and S.M. Watkins Genomics and metabolomics as markers for the interaction of diet and health: lessons from lipids J. Nutr. 133 Suppl. 1 2003 2078S 2083S
39. S. Ghaemmaghami, W.K. Huh, K. Bower, R.W. Howson, A. Belle, N. Dephoure, E.K. O'shea, and J.S. Weissman Global analysis of protein expression in yeast Nature 425 2003 737 741
40. R.A. Gibbs The international HapMap project (The International HapMap Consortium) Nature 426 2003 789 796
41. F.J. Gonzalez, R.C. Skoda, S. Kimura, M. Umeno, U.M. Zanger, D.W. Nebert, H.V. Gelboin, J.P. Hardwick, and U.A. Meyer Characterization of the common genetic defect in humans deficient in debrisoquine metabolism Nature 331 1988 442 446
42. I.P. Gorlov, O.Y. Gorlova, M.L. Frazier, and C.I. Amos Missense mutations in hMLH1 and hMSH2 are associated with exonic splicing enhancers Am. J. Hum. Genet. 73 2003 1157 1161
43. S. Gretarsdottir, G. Thorleifsson, S.T. Reynisdottir, A. Manolescu, S. Jonsdottir, T. Jonsdottir, T. Gudmundsdottir, S.M. Bjarnadottir, O.B. Einarsson, H.M. Gudjonsdottir, M. Hawkins, G. Gudmundsson, H. Gudmundsdottir, H. Andrason, A.S. Gudmundsdottir, M. Sigurdardottir, T.T. Chou, J. Nahmias, S. Goss, S. Sveinbjornsdottir, E.M. Valdimarsson, F. Jakobsson, U. Agnarsson, V. Gudnason, G. Thorgeirsson, J. Fingerle, M. Gurney, D. Gudbjartsson, M.L. Frigge, A. Kong, K. Stefansson, and J.R. Gulcher The gene encoding phosphodiesterase 4D confers risk of ischemic stroke Nat. Genet. 35 2003 131 138
44. G. Gudmundsson, S.E. Matthiasson, H. Arason, H. Johannsson, F. Runarsson, H. Bjarnason, K. Helgadottir, S. Thorisdottir, G. Ingadottir, K. Lindpaintner, J. Sainz, V. Gudnason, M.L. Frigge, A. Kong, J.R. Gulcher, and K. Stefansson Localization of a gene for peripheral arterial occlusive disease to chromosome 1p31 Am. J. Hum. Genet. 70 2002 586 592
45. J.G. Hall A clinician's plea Nat. Genet. 33 2003 440 442
46. T. Hansen, S.M. Echwald, L. Hansen, A.M. Moller, K. Almind, J.O. Clausen, S.A. Urhammer, H. Inoue, J. Ferrer, J. Bryan, L. Aguilar-Bryan, M.A. Permutt, and O. Pedersen Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene Diabetes 47 1998 598 605
47. C. Hassett, L. Aicher, J.S. Sidhu, and C.J. Omiecinski Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants Hum. Mol. Genet. 3 1994 421 428
48. I. Hellmann, I. Ebersberger, S.E. Ptak, S. Pääbo, and M. Przeworski A neutral explanation for the correlation of diversity with recombination rates in humans Am. J. Hum. Genet. 72 2003 1527 1535
49. D. Hernandez, S. Addou, D. Lee, C. Orengo, E.A. Shephard, and I.R. Phillips Trimethylaminuria and a human FMO3 mutation database Human Mutat. 22 2003 209 213
50. J.D. Horton, N.A. Shah, J.A. Warrington, N.N. Anderson, S.W. Park, M.S. Brown, and J.L. Goldstein Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes Proc. Natl. Acad. Sci. U. S. A. 100 2003 12027 12032
51. Y. Hu, M. Oscarson, I. Johansson, Q.Y. Yue, M.L. Dahl, M. Tabone, S. Arinco, E. Albano, and M. Ingelman-Sundberg Genetic polymorphism of human CYP2E1: characterization of two variant alleles Mol. Pharmacol. 51 1997 370 376
52. J.A. Humbert, K.B. Hammond, and W.E. Hathaway Trimethylaminuria: the fish-odour syndrome Lancet 2 1970 770 771
53. T. Ideker, T. Galitski, and L. Hood A new approach to decoding life: systems biology Annu. Rev. Genomics Hum. Genet. 2 2001 343 372
54. D.C. Inada, A. Bashir, C. Lee, B.C. Thomas, C. Ko, S.A. Goff, and M. Freeling Conserved noncoding sequences in the grasses Genome Res. 13 2003 2030 2041
55. M. Ingelman-Sundberg Pharmacogenetics of cytochrome P450 and its applications in personalised medicine: the past, present and future Trends Pharmacol. Sci. 25 2004 193 200
56. 2-adrenergic receptor on the response to regular use of albuterol in asthma Am. J. Respir. Crit. Care Med. 162 2000 75 80
57. A.J. Jeffreys, and C.A. May Intense and highly localized gene conversion activity in human meiotic crossover hot spots Nat. Genet. 36 2004 151 156
58. R. Jiang, J. Duan, A. Windemuth, J.C. Stephens, R. Judson, and C. Xu Genome-wide evaluation of the public SNP databases Pharmacogenomics 4 2003 779 789
59. I. Johansson, E. Lundqvist, L. Bertilsson, M.L. Dahl, F. Sjoqvist, and M. Ingelman-Sundberg Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultra-rapid metabolism of debrisoquine Proc. Natl. Acad. Sci. U. S. A. 90 1993 11825 11829
60. J.M. Johnson, J. Castle, P. Garrett-Engele, Z. Kan, P.M. Loerch, C.D. Armour, R. Santos, E.E. Schadt, R. Stoughton, and D.D. Shoemaker Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays Science 302 2003 2141 2144
61. Kaddurah-Daouk, R., May 2003. Presentation at Workshop on Metabolic Profiling: Application to Toxicology and Risk Reduction. Research Triangle Park, North Carolina. http://ehpnet1.niehs.nih.gov/docs/2003/111-13/extram-speaking. html.
62. J. Kaiser Pharmacogenomics. FDA puts the brakes on Roche's gene array test Science 302 2003 1134
63. W. Kalow, and K. Genest A method for the detection of atypical forms of human serum cholinesterase: determination of dibucaine numbers Can. J. Med. Sci. 35 1957 339 346
64. T. Katoh The frequency of glutathione-S-transferase M1 (GSTM1) gene deletion in patients with lung and oral cancer Sangyo Igaku 36 1994 435 439
65. Keun, H., May 2003. Consortium for Metabonomic Toxicology. Presentation at Workshop on Metabolic Profiling: Application to Toxicology and Risk Reduction. Research Triangle Park, North Carolina. http://www.niehs.nih.gov/ dert/council/2003/connelly.pdf.
66. F.L. Kiechle, and C.A. Holland-Staley Genomics, transcriptomics, proteomics, and numbers Arch. Pathol. Lab. Med. 127 2003 1089 1097
67. U.K. Kim, E. Jorgenson, H. Coon, M. Leppert, N. Risch, and D. Drayna Positional cloning of the human quantitative trait locus underlying taste sensitivity to phenylthiocarbamide Science 299 2003 1221 1225
68. R.A. King, R.K. Willaert, R.M. Schmidt, J. Pietsch, S. Savage, M.J. Brott, J.P. Fryer, C.G. Summers, and W.S. Oetting MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2) Am. J. Hum. Genet. 73 2003 638 645
69. N. Kioka, J. Tsubota, Y. Kakehi, T. Komano, M.M. Gottesman, I. Pastan, and K. Ueda P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multi-drug resistance Biochem. Biophys. Res. Commun. 162 1989 224 231
70. L. Kruglyak, and D.A. Nickerson Variation is the spice of life Nat. Genet. 27 2001 234 236
71. A. Kupfer, and R. Preisig Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man Eur. J. Clin. Pharmacol. 26 1984 753 759
72. V. Lamba, J. Lamba, K. Yasuda, S. Strom, J. Davila, M.L. Hancock, J.D. Fackenthal, P.K. Rogan, B. Ring, S.A. Wrighton, and E.G. Schuetz Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression J. Pharmacol. Exp. Ther. 307 2003 906 922
73. J. Lazarou, B.H. Pomeranz, and P.N. Corey Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies J. Am. Med. Assoc. 279 1998 1200 1205
74. S.J. Lee, K.A. Usmani, B. Chanas, B. Ghanayem, T. Xi, E. Hodgson, H.W. Mohrenweiser, and J.A. Goldstein Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups Pharmacogenetics 13 2003 461 472
75. L.A. Lettice, S.J. Heaney, L.A. Purdie, L. Li, P. de Beer, B.A. Oostra, D. Goode, G. Elgar, R.E. Hill, and E. de Graaff A long-range SHH enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly Hum. Mol. Genet. 12 2003 1725 1735
76. E. Levesque, M. Beaulieu, D.W. Hum, and A. Belanger Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene Pharmacogenetics 9 1999 207 216
77. B.P. Lewis, I.H. Shih, M.W. Jones-Rhoades, D.P. Bartel, and C.B. Burge Prediction of mammalian microRNA targets Cell 115 2003 787 798
78. J.L. Li, M.R. Hayden, E.W. Almqvist, R.R. Brinkman, A. Durr, C. Dode, P.J. Morrison, O. Suchowersky, C.A. Ross, R.L. Margolis, A. Rosenblatt, E. Gomez-Tortosa, D.M. Cabrero, A. Novelletto, M. Frontali, M. Nance, R.J. Trent, E. McCusker, R. Jones, J.S. Paulsen, M. Harrison, A. Zanko, R.K. Abramson, A.L. Russ, B. Knowlton, L. Djousse, J.S. Mysore, S. Tariot, M.F. Gusella, V.C. Wheeler, L.D. Atwood, L.A. Cupples, M. Saint-Hilaire, J.H. Cha, S.M. Hersch, W.J. Koroshetz, J.F. Gusella, M.E. MacDonald, and R.H. Myers A genome scan for modifiers of age at onset in Huntington disease: the HD MAPS study Am. J. Hum. Genet. 73 2003 682 687
79. 2-adrenergic receptor and asthma Am. J. Respir. Crit. Care Med. 156 1997 S156 S162
80. 2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure J. Clin. Invest. 102 1998 1534 1539
81. E.T. Liu, and K.R. Karaturi Microarrays and clinical investigations N. Engl. J. Med. 350 2004 1595 1597
82. C. Lonjou, W. Zhang, A. Collins, W.J. Tapper, E. Elahi, N. Maniatis, and N.E. Morton Linkage disequilibrium in human populations Proc. Natl. Acad. Sci. U. S. A. 100 2003 6069 6074
83. T.J. Lynch, D.W. Bell, R. Sordella, S. Gurubhagavatula, R.A. Okimoto, B.W. Brannigan, P.L. Harris, S.M. Haserlat, J.G. Supko, F.G. Haluska, D.N. Louis, D.C. Christiani, J. Settleman, and D.A. Haber Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib N. Engl. J. Med. 350 2004 2129 2139
84. D.H. MacLennan, C. Duff, F. Zorzato, J. Fujii, M. Phillips, R.G. Korneluk, W. Frodis, B.A. Britt, and R.G. Worton Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia Nature 343 1990 559 561
85. A. Mahgoub, J.R. Idle, L.G. Dring, R. Lancaster, and R.L. Smith Polymorphic hydroxylation of debrisoquine in man Lancet 2 1977 584 586
86. Malmebo, S., Ingelman-Sundberg, M., Daly, A.K., Nebert, D.W., 2004 Human cytochrome P450 (CYP) alleles [web site]. http.//www.imm.ki.se/CYPalleles.
87. G. Marais Biased gene conversion: implications for genome and sex evolution Trends Genet. 19 2003 330 338
88. E.H. Margulies, M. Blanchette, D. Haussler, and E.D. Green Identification and characterization of multi-species conserved sequences Genome Res. 13 2003 2507 2518 (NISC Comparative Sequencing Program, 2003)
89. P.A. Marks, and R.T. Gross Erythrocyte glucose-6-phosphate dehydrogenase deficiency: evidence of differences between Negroes and Caucasians with respect to this genetically determined trait J. Clin. Invest. 38 1959 2253 2262
90. M. Masellis, A.D. Paterson, F. Badri, J.A. Lieberman, H.Y. Meltzer, P. Cavazzoni, and J.L. Kennedy Genetic variation of 5-HT2A receptor and response to clozapine Lancet 346 1995 1108
91. D.P. McGovern, D.A. van Heel, K. Negoro, T. Ahmad, and D.P. Jewell Further evidence of IBD5/CARD15 (NOD2) epistasis in the susceptibility to ulcerative colitis Am. J. Hum. Genet. 73 2003 1465 1466
92. P.F. McGregor Gene expression in cancer: the application of microarrays Expert Rev. Mol. Diagn. 3 2003 185 200
93. P.M. McKeigue Mapping genes underlying ethnic differences in disease risk by linkage disequilibrium in recently admixed populations Am. J. Hum. Genet. 60 1997 188 196
94. R. Meinsma, P. Fernandez-Salguero, A.B. van Kuilenburg, A.H. van Gennip, and F.J. Gonzalez Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uracilurea DNA Cell Biol. 14 1995 1 6
95. G. Miltenberger-Miltenyi, and F. Laccone Mutations and polymorphisms in the human methyl CpG-binding protein gene MECP2 Human Mutat. 22 2003 107 115
96. D. Moncama, M.J. Arranz, and R.W. Kerwin Genetic predictors of therapeutic response to clozapine: current status of research CNS Drugs 16 2002 317 324
97. V. Mooser, D.M. Waterworth, T. Isenhour, and L. Middleton Cardiovascular pharmacogenetics in the SNP era Thromb. Haemost. 1 2003 1398 1402
98. S. Nagafuchi, H. Yanagisawa, K. Sato, T. Shirayama, E. Ohsaki, M. Bundo, T. Takeda, K. Tadokoro, I. Kondo, and N. Murayama Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p Nat. Genet. 6 1994 14 18
99. M. Nakajima, T. Yokoi, M. Mizutani, M. Kinoshita, M. Funayama, and T. Kamataki Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans J. Biochem. (Tokyo) 125 1999 803 808
100. D.W. Nebert Extreme discordant phenotype methodology: an intuitive approach to clinical pharmacogenetics Eur. J. Pharmacol. 410 2000 107 120
101. D.W. Nebert Transcription factors and cancer: an overview Toxicology 181-182 2002 131 141
102. D.W. Nebert, L.F. Jorge-Nebert, and E.S. Vesell Pharmacogenomics and "individualized drug therapy": high expectations and disappointing achievements Am. J. Pharmacogenomics 3 2003 361 370
103. D.R. Nelson Update on gene completions and annotations: "Frankenstein genes," or the Mad Magazine version of the human pseudogenome Hum. Genome 1 2004 310 316
104. M.M. Nothen, M. Rietschel, J. Erdmann, H. Oberlander, H.J. Moller, D. Nober, and P. Propping Genetic variation of the 5-HT2A receptor and response to clozapine Lancet 346 1995 908 909
105. B. Oliver, and B. Leblanc How many genes in a genome? Genome Biol. 5 2004 204
106. J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F.J. Kaye, N. Lindeman, T.J. Boggon, K. Naoki, H. Sasaki, Y. Fujii, M.J. Eck, W.R. Sellers, B.E. Johnson, and M. Meyerson EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
107. G.P. Page, V. George, R.C. Go, P.Z. Page, and D.B. Allison "Are we there yet?": deciding when one has demonstrated specific genetic causation in complex diseases and quantitative traits Am. J. Hum. Genet. 73 2003 711 719
108. E. Pennisi Bickering genes shape evolution Science 301 2003 1837 1839
109. R.S. Plumb, C.L. Stumpf, M.V. Gorenstein, J.M. Castro-Perez, G.J. Dear, M. Anthony, B.C. Sweatman, S.C. Connor, and J.N. Haselden Metabonomics: the use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development Rapid Commun. Mass Spectrom. 16 2002 1991 1996
110. R.S. Plumb, C.L. Stumpf, J.H. Granger, J. Castro-Perez, J.N. Haselden, and G.J. Dear Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids Rapid Commun. Mass Spectrom. 17 2003 2632 2638
111. S.H. Powis, I. Mockridge, A. Kelly, L.A. Kerr, R. Glynne, U. Gileadi, S. Beck, and J. Trowsdale Polymorphism in a second ABC transporter gene located within the class II region of the human major histocompatibility complex Proc. Natl. Acad. Sci. U. S. A. 89 1992 1463 1467
112. A. Puga, A. Maier, and M. Medvedovic The transcriptional signature of dioxin in human hepatoma HepG2 cells Biochem. Pharmacol. 60 2000 1129 1142
113. S.A. Quadri, and D.P. Singal Peptide transport in human lymphoblastoid and tumor cells: effect of transporter associated with antigen presentation (TAP) polymorphism Immunol. Lett. 61 1998 25 31
114. N.V. Reo NMR-based metabolomics Drug Chem. Toxicol. 25 2002 375 382
115. 2-macroglobulin insertion-deletion polymorphism in Alzheimer disease Nat. Genet. 22 1999 19 21
116. 2-Macroglobulin gene and Alzheimer disease Nat. Genet. 22 1999 17 19
117. B.A. Salisbury, M. Pungliya, J.Y. Choi, R. Jiang, X.J. Sun, and J.C. Stephens SNP and haplotype variation in the human genome Mutat. Res. 526 2003 53 61
118. V.D. Schmith, D.A. Campbell, S. Sehgal, W.H. Anderson, D.K. Burns, L.T. Middleton, and A.D. Roses Pharmacogenetics and disease genetics of complex diseases Cell. Mol. Life Sci. 60 2003 1636 1646
119. V. Schramke, and R. Allshire Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing Science 301 2003 1069 1074
120. E. Smeraldi, R. Zanardi, F. Benedetti, D. Di Bella, J. Perez, and M. Catalano Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine Mol. Psychiatry 3 1998 508 511
121. A.G. Smith, R. Davies, T.P. Dalton, M.L. Miller, D. Judah, J. Riley, T. Gant, and D.W. Nebert Intrinsic hepatic phenotype associated with the Cyp1a2 gene as shown by cDNA expression microarray analysis of the knockout mouse Environ. Health Perspect. 111 2003 855 861
122. L.H. Snyder Studies in human inheritance: IX. The inheritance of taste deficiency in man Ohio J. Sci. 32 1932 436 468
123. M. Srivastava, O. Eidelman, X. Leighton, M. Glasman, G. Goping, and H.B. Pollard ANX7 is required for nutritional control of gene expression in mouse pancreatic islets of Langerhans Mol. Med. 8 2002 781 797
124. H. Stefansson, J. Sarginson, A. Kong, P. Yates, V. Steinthorsdottir, E. Gudfinnsson, S. Gunnarsdottir, N. Walker, H. Petursson, C. Crombie, A. Ingason, J.R. Gulcher, K. Stefansson, and D. St Clair Association of neuregulin-1 with schizophrenia confirmed in a Scottish population Am. J. Hum. Genet. 72 2003 83 87
125. C.P. Strassburg, S. Kneip, J. Topp, P. Obermayer-Straub, A. Barut, R.H. Tukey, and M.P. Manns Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine J. Biol. Chem. 275 2000 36164 36171
126. U. Styrkarsdottir, J.B. Cazier, A. Kong, O. Rolfsson, H. Larsen, E. Bjarnadottir, V.D. Johannsdottir, M.S. Sigurdardottir, Y. Bagger, C. Christiansen, I. Reynisdottir, S.F. Grant, K. Jonasson, M.L. Frigge, J.R. Gulcher, G. Sigurdsson, and K. Stefansson Linkage of osteoporosis to chromosome 20p12 and association to BMP2 PLoS. Biol. 1 2003 E69
127. P.F. Sullivan, W.J. Fifield, M.A. Kennedy, R.T. Mulder, D. Sellman, and P.R. Joyce Novelty seeking and a dopamine transporter gene polymorphism (DAT1) Biol. Psychiatry 42 1997 1070 1072
128. J.E. Sutherland, and M. Costa Epigenetics and the environment Ann. N.Y. Acad. Sci. 983 2003 151 160
129. M. Taipale, N. Kaminen, J. Nopola-Hemmi, T. Haltia, B. Myllyluoma, H. Lyytinen, K. Muller, M. Kaaranen, P.J. Lindsberg, K. Hannula-Jouppi, and J. Kere A candidate gene for developmental dyslexia encodes a nuclear tetratricopeptide-repeat domain protein dynamically regulated in brain Proc. Natl. Acad. Sci. U. S. A. 100 2003 11553 11558
130. S. Takahara Progressive oral gangrene probably due to lack of catalase in the blood (acatalasaemia): report of nine cases Lancet 2 1952 1101 1104
131. Y.S. Teng Human liver aldehyde dehydrogenase in Chinese and Asiatic Indians: gene deletion and its possible implications in alcohol metabolism Biochem. Genet. 19 1981 107 114
132. R.D. Traver, T. Horikoshi, K.D. Danenberg, T.H. Stadlbauer, P.V. Danenberg, D. Ross, and N.W. Gibson NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity Cancer Res. 52 1992 797 802
133. J. van Aken, M. Schmedders, G. Feuerstein, and R. Kollek Prospects and limits of pharmacogenetics: the thiopurine methyltransferase (TPMT) experience Am. J. Pharmacogenomics 3 2003 147 155
134. K.M. van Asselt, H.S. Kok, H. Putter, C. Wijmenga, P.H. Peeters, Y.T. van der Schouw, D.E. Grobbee, E.R. te Velde, S. Mosselman, and P.L. Pearson Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age Am. J. Hum. Genet. 74 2004 444 453
135. V.J. Vieland, and J. Huang Two-locus heterogeneity cannot be distinguished from two-locus epistasis on the basis of affected-sib-pair data Am. J. Hum. Genet. 73 2003 223 232
136. 2-adrenergic receptor determine exercise capacity in patients with heart failure Circ. Res. 86 2000 834 840
137. 1-adrenergic receptor predict exercise capacity in heart failure Am. Heart J. 144 2002 840 846
138. J.D. Wall Close look at gene conversion hot spots Nat. Genet. 36 2004 114 115
139. R.A. Waterland, and R.L. Jirtle Transposable elements: targets for early nutritional effects on epigenetic gene regulation Mol. Cell. Biol. 23 2003 5293 5300
140. + channel Circulation 99 1999 3165 3171
141. R.M. Weinshilboum Phenol sulfotransferase inheritance Cell. Mol. Neurobiol. 8 1988 27 34
142. R. Weinshilboum Inheritance and drug response N. Engl. J. Med. 348 2003 529 537
143. R.M. Weinshilboum, and S.L. Sladek Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity Am. J. Hum. Genet. 32 1980 651 662
144. J.K. Wiencke, S. Pemble, B. Ketterer, and K.T. Kelsey Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis Cancer Epidemiol. Biomark. Prev. 4 1995 253 259
145. J. Williams, G. Spurlock, P. McGuffin, J. Mallet, M.M. Nothen, M. Gill, H. Aschauer, P.O. Nylander, F. Macciardi, and M.J. Owen Association between schizophrenia and 102T>C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group Lancet 347 1996 1294 1296
146. Y. Xing, R. Resch, and C. Lee The multi-assembly problem: reconstructing multiple transcript isoforms from EST fragment mixtures Genome Res. 14 2004 426 441
147. Z. Xuan, J. Wang, and M.Q. Zhang Computational comparison of two mouse draft genomes and the human golden path Genome Biol. 4 2003 R1
148. S. Yamano, P.T. Nhamburo, T. Aoyama, U.A. Meyer, T. Inaba, W. Kalow, H.V. Gelboin, O.W. McBride, and F.J. Gonzalez cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver Biochemistry 28 1989 7340 7348
149. Q. Yue, J.C. Jen, M.M. Thwe, S.F. Nelson, and R.W. Baloh De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia Am. J. Med. Genet. 77 1998 298 301
150. K. Zhang, J.M. Akey, N. Wang, M. Xiong, R. Chakraborty, and L. Jin Randomly distributed crossovers may generate block-like patterns of linkage disequilibrium: an act of genetic drift Hum. Genet. 113 2003 51 59
151. L.A. Zhivotovsky, N.A. Rosenberg, and M.W. Feldman Features of evolution and expansion of modern humans, inferred from genome-wide microsatellite markers Am. J. Hum. Genet. 72 2003 1171 1186
152. S. Zollner, X. Wen, N.A. Hanchard, M.A. Herbert, C. Ober, and J.K. Pritchard Evidence for extensive transmission distortion in the human genome Am. J. Hum. Genet. 74 2004 62 72